Poland· PL-100205905
Linomag
A medicinal product containing lini oleum virginale, registered in Poland by Przedsiębiorstwo Farmaceutyczne Ziołolek Sp. z o.o..
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Lini oleum virginale
- Manufacturer
- Przedsiębiorstwo Farmaceutyczne Ziołolek Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin05909990258512
- gtin05909990258529
- gtin05909991295202
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Lini oleum virginale in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/562b1ef4-5c7b-46a7-90b0-32e4b32954a5 GET /v1/drugs/562b1ef4-5c7b-46a7-90b0-32e4b32954a5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Krem",
"source": "urpl",
"strength": "200 mg/g",
"packaging": "05909990258512 ¦ OTC ¦ Skasowane ¦ 5858\n1 op. 30 g\n05909990258529 ¦ OTC ¦ 62755\n1 tuba 30 g\n05909991295202 ¦ OTC ¦ 117915\n1 tuba 100 g",
"substance": "Lini oleum 200 mg/g",
"common_name": "Lini oleum virginale",
"pl_product_id": "100205905",
"pozwolenie_nr": "02585",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about lini oleum virginale.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.